Department of Orthopaedic Surgery, University of Pennsylvania, Garfield Duncan Building, Suite 2C, 301 S 8th Street, Philadelphia, PA 19106-6192, USA.
Clin Orthop Relat Res. 2011 Jan;469(1):283-8. doi: 10.1007/s11999-010-1374-9. Epub 2010 May 12.
Solitary bone cysts (SBC), nonossifying fibromas (NOF), and fibrous dysplasia (FD) create benign intramedullary lytic bone lesions. They are typically asymptomatic and treated conservatively. We present a series of lesions that caused performance-limiting pain in young athletes, a symptom phenomenon and possible treatment indication that has been poorly described in the literature.
QUESTIONS/PURPOSES: We asked whether intralesional curettage and defect grafting of these lesions would alleviate pain in young athletes and permit their return to unrestricted athletic activities.
We retrospectively identified 29 patients (30 lesions) who underwent curettage and grafting for SBC (12 patients), NOF (nine), or FD (eight). All patients had pain predominantly with athletic involvement. The mean age of the patients was 18 years (range, 12-31 years). Tumor locations were the femur (eight lesions), humerus (seven), tibia (six), fibula (five), pubic ramus (two), ulna (one), and calcaneus (one). Signs/symptoms were pain alone (24 patients) and pain plus fracture (five). Surgery involved curettage and packing with allograft cancellous chips, bone substitute, or demineralized bone matrix. Two patients required internal fixation. The mean followup was 21 months (range, 2-114 months).
Twenty-four patients had no pain and five had occasional mild pain at last followup. All patients resumed full activity at a mean of 3.3 months (range, 1.5-8.3 months), excluding two who required repeat surgery.
Our observations suggest curettage and packing with bone graft/substitute can provide pain relief and allow full athletic recovery for young athletes with benign lytic bone lesions.
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
孤立性骨囊肿(SBC)、非骨化性纤维瘤(NOF)和纤维结构不良(FD)导致良性髓内溶骨性骨病变。这些病变通常无症状,采用保守治疗。我们报告了一系列病变,这些病变导致年轻运动员出现运动受限性疼痛,这种症状现象和可能的治疗指征在文献中描述甚少。
问题/目的:我们想知道对这些病变进行病灶内刮除和植骨能否缓解年轻运动员的疼痛,并使其恢复不受限制的运动活动。
我们回顾性地确定了 29 名患者(30 个病灶),他们因 SBC(12 名患者)、NOF(9 名患者)或 FD(8 名患者)接受了病灶刮除和植骨治疗。所有患者的疼痛主要与运动有关。患者的平均年龄为 18 岁(范围:12-31 岁)。肿瘤部位为股骨(8 个病灶)、肱骨(7 个病灶)、胫骨(6 个病灶)、腓骨(5 个病灶)、耻骨支(2 个病灶)、尺骨(1 个病灶)和跟骨(1 个病灶)。体征/症状为单纯疼痛(24 例)和疼痛合并骨折(5 例)。手术包括病灶刮除和同种异体松质骨骨屑、骨替代物或脱钙骨基质填充。2 例患者需要内固定。平均随访时间为 21 个月(范围:2-114 个月)。
24 例患者无疼痛,5 例患者最后随访时有轻度偶发性疼痛。所有患者平均在 3.3 个月(范围:1.5-8.3 个月)时恢复完全活动,有 2 例患者需要再次手术。
我们的观察结果表明,病灶刮除和植骨可以缓解疼痛,并使患有良性溶骨性骨病变的年轻运动员完全恢复运动。
IV 级,治疗性研究。请参阅作者指南以获取完整的证据水平描述。